Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor (original) (raw)

• Bottino, C., Moretta, L. & Moretta, A. NK cell activating receptors and tumor recognition in humans. Curr. Top. Microbiol. Immunol. 298, 175–182 (2006).
  CAS PubMed Google Scholar
• Newman, K.C. & Riley, E.M. Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nat. Rev. Immunol. 7, 279–291 (2007).
  Article CAS PubMed Google Scholar
• Lodoen, M.B. & Lanier, L.L. Natural killer cells as an initial defense against pathogens. Curr. Opin. Immunol. 18, 391–398 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Huntington, N.D., Vosshenrich, C.A. & Di Santo, J.P. Developmental pathways that generate natural-killer-cell diversity in mice and humans. Nat. Rev. Immunol. 7, 703–714 (2007).
  Article CAS PubMed Google Scholar
• Stewart, C.A. et al. Germ-line and rearranged Tcrd transcription distinguish bona fide NK cells and NK-like γδ T cells. Eur. J. Immunol. 37, 1442–1452 (2007).
  Article CAS PubMed Google Scholar
• Gregoire, C. et al. The trafficking of natural killer cells. Immunol. Rev. (in the press).
• Hokeness, K.L., Kuziel, W.A., Biron, C.A. & Salazar-Mather, T.P. Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-α/β-induced inflammatory responses and antiviral defense in liver. J. Immunol. 174, 1549–1556 (2005).
  Article CAS PubMed Google Scholar
• Thapa, M., Kuziel, W.A. & Carr, D.J. Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization. J. Virol. 81, 3704–3713 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Ajuebor, M.N. et al. CCR5 deficiency drives enhanced natural killer cell trafficking to and activation within the liver in murine T cell-mediated hepatitis. Am. J. Pathol. 170, 1975–1988 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Khan, I.A. et al. CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection. PLoS Pathog 2, e49 (2006).
  Article PubMed PubMed Central Google Scholar
• Martin-Fontecha, A. et al. Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming. Nat. Immunol. 5, 1260–1265 (2004).
  Article CAS PubMed Google Scholar
• Jiang, D. et al. Regulation of pulmonary fibrosis by chemokine receptor CXCR3. J. Clin. Invest. 114, 291–299 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Huang, D. et al. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J. 20, 896–905 (2006).
  Article CAS PubMed Google Scholar
• Yu, Y.R. et al. Defective antitumor responses in CX3CR1-deficient mice. Int. J. Cancer 121, 316–322 (2007).
  Article CAS PubMed Google Scholar
• Lavergne, E. et al. Fractalkine mediates natural killer-dependent antitumor responses in vivo. Cancer Res. 63, 7468–7474 (2003).
  CAS PubMed Google Scholar
• Wald, O. et al. IFN-γ acts on T cells to induce NK cell mobilization and accumulation in target organs. J. Immunol. 176, 4716–4729 (2006).
  Article CAS PubMed Google Scholar
• Inngjerdingen, M., Damaj, B. & Maghazachi, A.A. Expression and regulation of chemokine receptors in human natural killer cells. Blood 97, 367–375 (2001).
  Article CAS PubMed Google Scholar
• Geissmann, F. et al. Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol. 3, e113 (2005).
  Article PubMed PubMed Central Google Scholar
• Cyster, J.G. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu. Rev. Immunol. 23, 127–159 (2005).
  Article CAS PubMed Google Scholar
• Rosen, H. & Goetzl, E.J. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat. Rev. Immunol. 5, 560–570 (2005).
  Article CAS PubMed Google Scholar
• Rosen, H., Sanna, M.G., Cahalan, S.M. & Gonzalez-Cabrera, P.J. Tipping the gatekeeper: S1P regulation of endothelial barrier function. Trends Immunol. 28, 102–107 (2007).
  Article CAS PubMed Google Scholar
• Brinkmann, V. Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology. Pharmacol. Ther. 115, 84–105 (2007).
  Article CAS PubMed Google Scholar
• Schwab, S.R. et al. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 309, 1735–1739 (2005).
  Article CAS PubMed Google Scholar
• Matloubian, M. et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427, 355–360 (2004).
  Article CAS PubMed Google Scholar
• Wei, S.H. et al. Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses. Nat. Immunol. 6, 1228–1235 (2005).
  Article CAS PubMed Google Scholar
• Terai, K. et al. Edg-8 receptors are preferentially expressed in oligodendrocyte lineage cells of the rat CNS. Neuroscience 116, 1053–1062 (2003).
  Article CAS PubMed Google Scholar
• Im, D.S. et al. Characterization of a novel sphingosine 1-phosphate receptor, Edg-8. J. Biol. Chem. 275, 14281–14286 (2000).
  Article CAS PubMed Google Scholar
• Jaillard, C. et al. Edg8/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survival. J. Neurosci. 25, 1459–1469 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Walzer, T. et al. Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc. Natl. Acad. Sci. USA 104, 3384–3389 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Walzer, T., Jaeger, S., Chaix, J. & Vivier, E. Natural killer cells: from CD3−NKp46+ to post-genomics meta-analyses. Curr. Opin. Immunol. 19, 365–372 (2007).
  Article CAS PubMed Google Scholar
• Goetzl, E.J. & Rosen, H. Regulation of immunity by lysosphingolipids and their G protein-coupled receptors. J. Clin. Invest. 114, 1531–1537 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Lucas, M., Schachterle, W., Oberle, K., Aichele, P. & Diefenbach, A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26, 503–517 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Mortier, E. et al. Soluble interleukin-15 receptor α (IL-15R α)-sushi as a selective and potent agonist of IL-15 action through IL-15Rβ/γ. Hyperagonist IL-15 x IL-15Rα fusion proteins. J. Biol. Chem. 281, 1612–1619 (2006).
  Article CAS PubMed Google Scholar
• Hayakawa, Y. & Smyth, M.J. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J. Immunol. 176, 1517–1524 (2006).
  Article CAS PubMed Google Scholar
• Goetzl, E.J., Kong, Y. & Mei, B. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax. J. Immunol. 162, 2049–2056 (1999).
  CAS PubMed Google Scholar
• Wang, W., Graeler, M.H. & Goetzl, E.J. Physiological sphingosine 1-phosphate requirement for optimal activity of mouse CD4+ regulatory T Cells. FASEB J. 18, 1043–1045 (2004).
  Article CAS PubMed Google Scholar
• Graeler, M. & Goetzl, E.J. Activation-regulated expression and chemotactic function of sphingosine 1-phosphate receptors in mouse splenic T cells. FASEB J. 16, 1874–1878 (2002).
  Article CAS PubMed Google Scholar
• Kveberg, L., Bryceson, Y., Inngjerdingen, M., Rolstad, B. & Maghazachi, A.A. Sphingosine 1 phosphate induces the chemotaxis of human natural killer cells. Role for heterotrimeric G proteins and phosphoinositide 3 kinases. Eur. J. Immunol. 32, 1856–1864 (2002).
  Article CAS PubMed Google Scholar
• Wang, J., Xu, J.W., Zhang, W.C., Wei, H.M. & Tian, Z.G. TLR3 ligand-induced accumulation of activated splenic natural killer cells into liver. Cell. Mol. Immunol. 2, 449–453 (2005).
  CAS PubMed Google Scholar
• Mandala, S. et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296, 346–349 (2002).
  Article CAS PubMed Google Scholar
• Chen, S., Kawashima, H., Lowe, J.B., Lanier, L.L. & Fukuda, M. Suppression of tumor formation in lymph nodes by L-selectin-mediated natural killer cell recruitment. J. Exp. Med. 202, 1679–1689 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Bajenoff, M. et al. Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J. Exp. Med. 203, 619–631 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Kelly, P., Casey, P.J. & Meigs, T.E. Biologic functions of the G12 subfamily of heterotrimeric G proteins: growth, migration, and metastasis. Biochemistry 46, 6677–6687 (2007).
  Article CAS PubMed Google Scholar
• Novgorodov, A.S., El-Alwani, M., Bielawski, J., Obeid, L.M. & Gudz, T.I. Activation of sphingosine-1-phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration. FASEB J. 21, 1503–1514 (2007).
  Article CAS PubMed Google Scholar
• Hanessian, S., Charron, G., Billich, A. & Guerini, D. Constrained azacyclic analogues of the immunomodulatory agent FTY720 as molecular probes for sphingosine 1-phosphate receptors. Bioorg. Med. Chem. Lett. 17, 491–494 (2007).
  Article CAS PubMed Google Scholar
• Freud, A.G. & Caligiuri, M.A. Human natural killer cell development. Immunol. Rev. 214, 56–72 (2006).
  Article CAS PubMed Google Scholar
• Ferlazzo, G. et al. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J. Immunol. 172, 1455–1462 (2004).
  Article CAS PubMed Google Scholar
• Vaessen, L.M., van Besouw, N.M., Mol, W.M., Ijzermans, J.N. & Weimar, W. FTY720 treatment of kidney transplant patients: a differential effect on B cells, naive T cells, memory T cells and NK cells. Transpl. Immunol. 15, 281–288 (2006).
  Article CAS PubMed Google Scholar
• Ljunggren, H.G. & Malmberg, K.J. Prospects for the use of NK cells in immunotherapy of human cancer. Nat. Rev. Immunol. 7, 329–339 (2007).
  Article CAS PubMed Google Scholar
• Chiesa, S. et al. Multiplicity and plasticity of natural killer cell signaling pathways. Blood 107, 2364–2372 (2005).
  Article PubMed Google Scholar
• Walzer, T., Arpin, C., Beloeil, L. & Marvel, J. Differential in vivo persistence of two subsets of memory phenotype CD8 T cells defined by CD44 and CD122 expression levels. J. Immunol. 168, 2704–2711 (2002).
  Article CAS PubMed Google Scholar